ArticleFrontiers in public health2026
Joinpoint regression and age-period-cohort analyses of global and Chinese acute hepatitis C incidence trends, 1990-2021.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to analyse the temporal trends of acute hepatitis C incidence and the independent effects of age, time period, and birth cohort (age-period-cohort effects) from 1990 to 2021 globally and in China. Methods: Data were obtained from the Global Burden of Disease Study 2021. Joinpoint regression was used to analyse the trends in age-standardized incidence rates (ASIRs). The age-period-cohort model was employed to disentangle the underlying effects of population ageing, temporal changes, and birth cohort risks. Results: From 1990 to 2021, the global ASIR of acute hepatitis C exhibited an overall declining trend (average annual percent change [AAPC] = -0.38%). However, this trend reversed after 2015, indicating a concerning resurgence. Disparities were pronounced across socio-demographic index (SDI) levels: Low-SDI regions faced the highest burden, while the ASIR in China declined most rapidly (AAPC = -1.55%). The age-period-cohort analysis revealed a bimodal age pattern, with peaks in early childhood (0-4 years) and old age (≥95 years), indicating distinct transmission routes and historical cohort risks. Conclusion: Despite a long-term decline, the global increase in acute hepatitis C incidence underscores an ongoing public health challenge. Our findings highlight the urgent need to strengthen prevention and screening strategies, particularly in low-SDI regions, among vulnerable age groups, and for high-risk populations in order to achieve the goal of hepatitis C elimination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.